Bristol-Myers Squibb Company
NYSE: BMY
$49.41
+$0.39 (+0.8%)
Closing Price on September 20, 2024
BMY Articles
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning.
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Giddy investors continued pouring money into U.S. stocks last week, and insiders continued their steady purchases at companies where they work or have a large position on file.
Published:
Last Updated:
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
Published:
Last Updated:
Tuesday, February 21, 2017, saw three large companies in the news after activist investors have targeted them. Investors have taken mixed reactions to each effort.
Published:
Last Updated:
2016's 50 most innovative companies are topped by Apple, Google and Tesla. Among the companies making the biggest moves were Netflix and Facebook, and new entrants on the list included Uber and...
Published:
Last Updated:
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Published:
Last Updated:
Bristol-Myers, Mattel, DryShips, and FuelCell Energy posted new 52-week lows Thursday.
Published:
Last Updated:
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
Published:
Last Updated:
Bristol-Myers, DryShips, Michaels, and Meridian Bioscience sink into Wednesday's 52-week low club.
Published:
Last Updated:
The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already out of the way.
Published:
Last Updated:
Bristol-Myers, DryShips, Target, and Fitbit posted new 52-week lows on Friday.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday include Alphabet, Amazon, Bristol-Myers, CBS, Check Point, CSX, Facebook and PayPal.
Published:
Last Updated: